Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberley Smith

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Hospital Infection|May 4, 2026
Respiratory Cross Infection in Non-Invasive Ventilator Devices (ResCIND)George T P Tay, Kimberley Smith, Congrong He, et al.
Joint Commission Journal on Quality and Patient Safety|September 17, 2025
Improving Door-to-ECG Time at a Quaternary Care Emergency DepartmentMichael D Stocker, Chrissie Schaeffer, Randy Cox, et al.
The American Journal of Cardiology|July 22, 2008
Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shockLaurent Bonello, Axel De Labriolle, Probal Roy, et al.
JACC. Basic to Translational Science|December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized TrialThorsten M Leucker, William O Osburn, Paula Reventun, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Hospital Infection|May 4, 2026
Respiratory Cross Infection in Non-Invasive Ventilator Devices (ResCIND)George T P Tay, Kimberley Smith, Congrong He, et al.
Joint Commission Journal on Quality and Patient Safety|September 17, 2025
Improving Door-to-ECG Time at a Quaternary Care Emergency DepartmentMichael D Stocker, Chrissie Schaeffer, Randy Cox, et al.
The American Journal of Cardiology|July 22, 2008
Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shockLaurent Bonello, Axel De Labriolle, Probal Roy, et al.
JACC. Basic to Translational Science|December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized TrialThorsten M Leucker, William O Osburn, Paula Reventun, et al.
Pageof 2